Robert H. Lurie Comprehensive Cancer Center of Northwestern University
In research, Robert H. Lurie Comprehensive Cancer Center of Northwestern University stands highest in Life Sciences (#1,331 of 7,800 worldwide), Medicine (#1,925 of 10,443 worldwide) and Health Sciences (#2,687 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 8.3× its share of world research.
- World rank, 2022–2025
- #3,060 of 28,054 · #3,610 all time
- Rank in ??
- #32 of 692
- Research works
- 1.6k ◆ 1% vs 2013–17
- Citations
- 86k 54.0 per fractional work
- Top-10% rate
- 26.5% record average 16.5%
- Open access
- 48% world 28%
What is Robert H. Lurie Comprehensive Cancer Center of Northwestern University known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #1,331 of 7,800 | 31.3% | 103 | #1902 | |
| MedicineField | #1,925 of 10,443 | 24.3% | 176 | #1233 | |
| Health SciencesDomain | #2,687 of 11,982 | 24.0% | 188 | #1598 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,598 of 3,579 | 29.2% | 79 | #1890 |
Each strip is that field’s whole ranked pool, with the notch where Robert H. Lurie Comprehensive Cancer Center of Northwestern University sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#1,902 #1,331
- Medicine#1,233 #1,925
- Health Sciences#1,598 #2,687
- Biochemistry, Genetics and Molecular Biology#1,890 #1,598
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Robert H. Lurie Comprehensive Cancer Center of Northwestern University specialise in?
Where its research is concentrated relative to its size: Oncology takes 8.3× the share of its output that it takes of world research.
- OncologySubfield · 29.9 works8.3×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.1×. Every wedge is a field page.
- Immunology and Microbiology 5.1×
- Biochemistry, Genetics and Molecular Biology 4.6×
- Medicine 2.9×
- Nursing 1.6×
- Health Professions 1.1×
- Neuroscience 0.9×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Psychology 0.6×
- Economics, Econometrics and Finance 0.5×
- Chemistry 0.3×
- Materials Science 0.2×
- Chemical Engineering 0.2×
- Dentistry 0.2×
- Decision Sciences 0.1×
- Social Sciences 0.1×
- Environmental Science 0.1×
- Engineering 0.1×
- Physics and Astronomy 0.1×
- Agricultural and Biological Sciences 0.1×
- Earth and Planetary Sciences 0.1×
- Computer Science 0.1×
- Arts and Humanities 0.0×
- Business, Management and Accounting 0.0×
- Mathematics 0.0×
Who are the top researchers at Robert H. Lurie Comprehensive Cancer Center of Northwestern University?
Ranked on the composite score, Nancy Krett and Cormac Cosgrove lead among researchers whose main affiliation is Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
- 1 Nancy Krett ?? · #1,110,481 worldwide 70 citations · 17 works
- 2 Cormac Cosgrove ?? · #1,410,376 worldwide 10 citations · 15 works
Which keywords describe research at Robert H. Lurie Comprehensive Cancer Center of Northwestern University?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Cancer, Prognostic Factors, Tumor Microenvironment, Radiotherapy, Inflammation, Cancer Immunotherapy and Immunity.
- Therapeutic Targets
- Cancer Progression
- AML
- CAR T Cells
- Leukemia
- Cell Death
- PET Imaging
- Transcriptional Regulation
- Hematopoietic Stem Cells
- Glioblastoma
- Innate Immunity
- Clinical Trials
- Biomarkers
- Targeted Therapy
- Lymphoma
- Immunity
- Radiotherapy
- Tumor Microenvironment
- Inflammation
- Cancer
- Immunotherapy
- Epidemiology
- Prognostic Factors
- Chemotherapy
- Cancer Therapy
- Cancer Immunotherapy
- Molecular Classification
- Gene Expression
- Genetic Mutations
- Tumor Regression
- Metabolism
- Temozolomide
- Stem Cells
- Genomic Instability
- Rituximab
- Cell-Free DNA
- Breast Cancer
- Chimeric Antigen Receptor
- Acute Myeloid Leukemia
- DNA Methylation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy26▲ 11×17 topics
- Cancer24▲ 5.6×42 topics
- Epidemiology20▲ 1.57×83 topics
- Inflammation18▲ 2.6×52 topics
- Prognostic Factors17▲ 12×14 topics
- Tumor Microenvironment15▲ 10×8 topics
- Chemotherapy12▲ 5.2×20 topics
- Radiotherapy11▲ 9.1×12 topics
- Cancer Therapy10▲ 5.6×16 topics
- Immunity10▲ 7.8×10 topics
- Cancer Immunotherapy10▲ 20×3 topics
- Lymphoma9▲ 17×3 topics
- Molecular Classification8▲ 17×4 topics
- Targeted Therapy8▲ 11×5 topics
- Gene Expression8▲ 4.0×15 topics
- Biomarkers8▲ 3.5×12 topics
- Genetic Mutations8▲ 5.5×18 topics
- Clinical Trials7▲ 3.5×14 topics
- Tumor Regression7▲ 21×2 topics
- Innate Immunity7▲ 6.8×9 topics
- Metabolism7▲ 4.2×16 topics
- Glioblastoma7▲ 31×1 topic
- Temozolomide7▲ 31×1 topic
- Hematopoietic Stem Cells6▲ 22×3 topics
- Stem Cells6▲ 7.0×15 topics
- Transcriptional Regulation6▲ 11×7 topics
- Genomic Instability6▲ 16×3 topics
- PET Imaging6▲ 10×4 topics
- Rituximab6▲ 12×4 topics
- Cell Death6▲ 7.4×6 topics
- Cell-Free DNA6▲ 18×2 topics
- Leukemia6▲ 20×2 topics
- Breast Cancer5▲ 7.0×9 topics
- CAR T Cells5▲ 23×1 topic
- Chimeric Antigen Receptor5▲ 23×1 topic
- AML5▲ 33×1 topic
- Acute Myeloid Leukemia5▲ 33×1 topic
- Cancer Progression5▲ 8.8×8 topics
- DNA Methylation5▲ 14×3 topics
- Therapeutic Targets5▲ 10×7 topics
Which research topics does Robert H. Lurie Comprehensive Cancer Center of Northwestern University publish most on?
By volume in 2022–2025: Glioma Diagnosis and Treatment, CAR-T cell therapy research, Acute Myeloid Leukemia Research and Cancer Genomics and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Glioma Diagnosis and Treatment Genetics 7 works
- 2 CAR-T cell therapy research Oncology 5 works
- 3 Acute Myeloid Leukemia Research Hematology 5 works
- 4 Cancer Genomics and Diagnostics Cancer Research 5 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 5 works
- 6 Immune cells in cancer Immunology 4 works
- 7 Epigenetics and DNA Methylation Molecular Biology 4 works
- 8 Immunotherapy and Immune Responses Immunology 4 works
- 9 Protein Degradation and Inhibitors Molecular Biology 3 works
- 10 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Robert H. Lurie Comprehensive Cancer Center of Northwestern University's research output changed?
Output in 2018–2022 was 1% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Chicago
- Exelon (United States)
- Northern Trust (United States)
- University of Chicago Medicine Comprehensive Cancer Center
- Chan Zuckerberg Biohub Chicago
- BAND foundation
- Molson Coors Brewing Company (United States)
- I AM ALS
- Neurocritical Care Society
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.